Qiagen NV

NYSE:QGENUnited States

Nov 4, 2024

Show headlines and story abstract

• QIAGEN Says FDA Cleared QIAstat-Dx Panel for Meningitis/Encephalitis, from 3:46AM ET on Monday Nov 04, 2024 by MT Newswires

  3:46AM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: QGEN
  03:46 AM EST, 11/04/2024 (MT Newswires) -- QIAGEN (QGEN) said Monday that the US Food and Drug Administration has approved for clinical use the company's QIAstat-Dx panel for meningitis and encephalitis. The approval marks the fourth FDA-approved QI...

• QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics, from 1:30AM ET on Monday Nov 04, 2024 by Dow Jones

  1:30AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: QGEN
  
  QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
  
  QIAstat-Dx Meningitis/Encephalitis Panel cleared in the U.S. for use in clinical settings to help diagnose central nervous system infections // Fourth FDA clearance marks milestone in 2024 in successful expansion of QIAstat--Dx tests developed specifically for the U.S. // QIAGEN now offers broad menu with FDA-cleared tests for respiratory, gastrointestinal and central nervous system infections -- and plans for further expansion // QIAstat-Dx delivers results in about one hour with real-time PCR, ensuring fast and accurate results to support clinical decision-making